Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026
Key Highlights
- ➤Lucid schedules Q3 2026 business update call for November 12 at 8:30 AM ET
- ➤CEO Lishan Aklog will discuss operations and growth strategy
- ➤CFO Dennis McGrath will discuss third-quarter 2026 financial results
- ➤Lucid markets EsoGuard and EsoCheck for early esophageal cancer detection
Expert Statements
Lishan Aklog, M.D., Chairman and Chief Executive Officer of Lucid Diagnostics
“will provide a business update and discuss the Company’s operations and growth strategy”
Dennis McGrath, Chief Financial Officer of Lucid Diagnostics
“will discuss the Company’s third quarter 2026 financial results”
Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026 PR Newswire
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it will host a business update conference call and webcast on Thursday, November 12, 2026, at 8:30 AM ET. During the call, Lishan Aklog, M.D. , Lucid's Chairman and Chief Executive Officer, will provide a business update and discuss the Company's operations and growth strategy. In addition, Dennis McGrath , Lucid's Chief Financial Officer, will discuss the Company's third quarter 2026 financial results.
Get started
Create a free account to read the full story.